Publishing research using ab120265? Please let us know so that we can cite the reference in this datasheet.
ab120265 has been referenced in 4 publications.
Miwa H & Kondo T T-type calcium channel as a new therapeutic target for tremor.Cerebellum 10:563-9 (2011).
Taylor JT et al.Selective blockade of T-type Ca2+ channels suppresses human breast cancer cell proliferation.Cancer Lett 267:116-24 (2008).
Li M et al.Towards selective antagonists of T-type calcium channels: design, characterization and potential applications of NNC 55-0396.Cardiovasc Drug Rev 23:173-96 (2005).
Huang L et al.NNC 55-0396 [(1S,2S)-2-(2-(N-[(3-benzimidazol-2-yl)propyl]-N-methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphtyl cyclopropanecarboxylate dihydrochloride]: a new selective inhibitor of T-type calcium channels.J Pharmacol Exp Ther 309:193-9 (2004).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"